2m 2m 2m 2m 2m 2m 2m
ENVERIC BIOSCIE (ENVB)
NASDAQ
$1.40-$0.03 (-2.45%)
Price as of Aug 21, 2026 7:42 PM EDT- $6.4MMarket Cap
- -90.23%1-Year Change
- BiotechnologyIndustry
ENVERIC BIOSCIE (ENVB)
$1.40-$0.03 (-2.45%)
ENVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.43 | ||
Change | +$0.04 (+2.88%) | ||
Open | $1.40 | ||
High | $1.44 | ||
Low | $1.38 | ||
Previous Close | $1.39 | ||
Volume | 89,150 | ||
30-Day Average Volume | 143,744 | ||
1-Week Change | -6.84% | ||
1-Month Change | 8.33% | ||
1-Year Change | -90.23% | ||
3-Year Change | -99.66% | ||
5-Year Change | -99.99% | ||
Fundamentals | |||
Shares Outstanding | 4.5M | ||
Total Assets | $8.9M | ||
Market Cap | $6.4M | ||
Enterprise Value | -$1.9M | ||
Period: QTR TTM FY | |||
Revenue | -$292.00 | ||
Net Income | -$3.0M | ||
Free Cash Flow | -$2.4M | ||
EBIT | -$3.0M | ||
EBITDA | -$3.0M | ||
Net Working Capital | $7.9M | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | 6,492 | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 10/28/2025 | ||
Earnings & Revenue